The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy

M. A. Blazing, James A de Lemos, C. K. Dyke, R. M. Califf, D. Bilheimer, E. Braunwald

Research output: Contribution to journalArticlepeer-review

94 Scopus citations

Fingerprint

Dive into the research topics of 'The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences